Empatica

Empatica Inc. is a medical technology and digital health company that focuses on AI-enabled wearable devices and software platforms for continuous health monitoring and neurological research.

Founded in 2011 as a spinoff from the MIT Media Lab, Empatica is headquartered in Boston, Massachusetts, with additional offices in Milan, Italy, and Seoul, South Korea. The company specializes in developing FDA-cleared technologies for seizure monitoring and aims to provide real-time health insights through its innovative solutions. Empatica offers a range of services, including continuous health monitoring, remote patient monitoring, and clinical trial support. Their product lineup features medical-grade wearables like the EmbracePlus and Embrace2, which are designed for epilepsy monitoring and provide real-time alerts for caregivers. The company serves various customer segments, including patients, healthcare providers, research institutions, and pharmaceutical companies, delivering tools that enhance patient care and support clinical research. With a commitment to advancing health technology, Empatica is positioned as a leader in the HealthTech and Biotechnology sectors.